| A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma (NCT07464925) | Tetragon Biosciences Ltd | 2026-04-20 |
| First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase Insufficiency (NCT07136922) | Calla Lily Clinical Care Ltd | 2026-04-20 |
| A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 in Healthy Participants (NCT07522970) | LinGang Laboratory | 2026-04-20 |
| A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma (NCT07569042) | Novelwise Pharmaceutical Corporation | 2026-04-20 |
| GS1-144 in Participants With Hepatic Impairment and Healthy Female (NCT07491289) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-04-20 |
| A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions (NCT07421414) | Boryung Pharmaceutical Co., Ltd | 2026-04-19 |
| Comparative Effectiveness of Clindamycin-Retinoid, Clindamycin-Retinoid-Dexamethasone, and 10% SM-hUCMSC Secretome Gel in the Improvement of Mild-to-Moderate Acne Vulgaris (NCT07504822) | Yohanes Firmansyah, dr, MH, MM | 2026-04-18 |
| Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration (NCT07554222) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-04-18 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria (NCT07241234) | Agios Pharmaceuticals, Inc. | 2026-04-17 |
| A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers (NCT07226843) | Eli Lilly and Company | 2026-04-17 |
| A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC (NCT07416695) | Shanghai Henlius Biotech | 2026-04-17 |
| Phase Ib Trial of Injectable RAB001 for Knee Osteoarthritis (NCT07652372) | ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. | 2026-04-16 |
| Scar Remodeling After Burn Injury Using Allogeneic Adipose-derived Stromal Cells (NCT07635875) | Rigshospitalet, Denmark | 2026-04-16 |
| Safety and Tolerability of ZE74-0282 in Healthy Volunteers (NCT07527221) | Eilean Therapeutics AU Pty Ltd | 2026-04-16 |
| A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants (NCT07534592) | AstraZeneca | 2026-04-16 |
| A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa (NCT06891885) | Sumitomo Pharma America, Inc. | 2026-04-16 |
| A Study of SA030 Injection in Overweight or Obese Participants (NCT07479862) | Suzhou Siran Biotechnology Co.,Ltd. | 2026-04-16 |
| Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia (NCT07476183) | Apriligen, Inc. | 2026-04-16 |
| To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma (NCT07454187) | Hangzhou Sumgen Biotech Co., Ltd. | 2026-04-16 |
| Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy (NCT05871606) | Wake Forest University Health Sciences | 2026-04-16 |
| A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer (NCT07439094) | Chong Kun Dang Pharmaceutical | 2026-04-16 |
| A Study of LY03015 in Healthy Chinese and Caucasian Adult Subjects (NCT07671833) | Luye Pharma Group Ltd. | 2026-04-15 |
| Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis (NCT07340138) | Novartis Pharmaceuticals | 2026-04-15 |
| Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer (NCT07545811) | Janux Therapeutics | 2026-04-15 |
| Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Primary Ovarian Insufficiency (NCT07551895) | Shenzhen Huishan Biotechnology Co., Ltd. | 2026-04-15 |
| A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1 (NCT07275606) | ViiV Healthcare | 2026-04-15 |
| Phase I Clinical Study to Evaluate SYS6055 Injection in Participants With Relapsed/Refractory B-Cell Malignancies (NCT07493174) | Institute of Hematology & Blood Diseases Hospital, China | 2026-04-15 |
| A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD) (NCT07282847) | AskBio Inc | 2026-04-15 |
| Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies (NCT07485504) | Tcelltech Inc. | 2026-04-15 |
| Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3) (NCT07496229) | Dizal Pharmaceuticals | 2026-04-15 |
| Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age (NCT07516418) | Sanofi | 2026-04-15 |
| Baricitinib for Post-HSCT Persistent Thrombocytopenia (NCT07535645) | Peking University People's Hospital | 2026-04-15 |
| Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors (NCT07482592) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-04-15 |
| Probiotic Delivered to the Small Intestine Changes Microbiota (NCT07510282) | University College Dublin | 2026-04-15 |
| A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function (NCT07519135) | Pfizer | 2026-04-15 |
| Effects of 5-Methyltetrahydrofolic Acid Supplementation on Maternal Health and One-Carbon Metabolism During Lactation (NCT07508917) | Fundació Sant Joan de Déu | 2026-04-15 |
| PK and Relative Bioavailability of Novel Liquid Metformin vs Tablets (NCT07300020) | Aspargo Labs, Inc | 2026-04-15 |
| Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention (NCT07084129) | Children's Hospital of Philadelphia | 2026-04-15 |
| Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia (NCT07473713) | Tufts Medical Center | 2026-04-15 |
| Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia (NCT07605845) | Gliknik Inc. | 2026-04-14 |
| Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment (NCT07651878) | Mendus | 2026-04-14 |
| A Study of GEN1106 in Participants With Solid Tumors (NCT07416123) | Genmab | 2026-04-14 |
| A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants (NCT07479641) | Shandong Suncadia Medicine Co., Ltd. | 2026-04-14 |
| A Single Ascending Dose Study of SYH2082 Injection in Healthy Participants (NCT07532655) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2026-04-14 |
| A Study of SHR-2524 Plus Bevacizumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (NCT07478302) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2026-04-14 |
| A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants (NCT07511218) | Ausper Biopharma Co., Ltd. | 2026-04-13 |
| Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors (NCT07517198) | Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 2026-04-13 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults (NCT07235163) | Pfizer | 2026-04-13 |
| ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium (NCT07414940) | University College, London | 2026-04-13 |
| Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma (NCT07249905) | ModeX Therapeutics, An OPKO Health Company | 2026-04-13 |
| A Study of SYH2082 Injection in Healthy Participants (NCT07736404) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2026-04-13 |
| A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants (NCT07443059) | Beijing QL Biopharmaceutical Co.,Ltd | 2026-04-13 |
| A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir (NCT07552779) | Pfizer | 2026-04-13 |
| To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers (NCT07514780) | JW Pharmaceutical | 2026-04-13 |
| A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors (NCT07414836) | BeOne Medicines | 2026-04-13 |
| A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fasting Conditions (NCT07421401) | Boryung Pharmaceutical Co., Ltd | 2026-04-13 |
| Inhibiting the Anti-apoptotic Factor, BCL-2, at the Time of ART Initiation to Promote Apoptosis of HIV-infected Cells and Restrict the Seeding of the HIV Reservoir (The INITIATE Study) (NCT07481175) | Thomas Aagaard Rasmussen | 2026-04-13 |
| Study on the Mass Balance of [14C]HRS-9190 for Injection in Healthy Participants (NCT07494175) | Jiangsu HengRui Medicine Co., Ltd. | 2026-04-11 |
| Relative Bioavailability and Impact of Rabeprazole for PF-07799933, Food-Effect for PF-07799933 and PF-07799544 (NCT07563894) | Pfizer | 2026-04-10 |
| Controlling Hyperactive Immunity With Long-lived Lymphocytes (NCT07473154) | Quell Therapeutics Limited | 2026-04-10 |
| A Study of Mirdametinib in People With Central Nervous System Tumors (NCT07539441) | Memorial Sloan Kettering Cancer Center | 2026-04-10 |
| Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Systemic Sclerosis (NCT07535931) | Shenzhen Huishan Biotechnology Co., Ltd. | 2026-04-10 |
| A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants (NCT07497503) | Syneos Health | 2026-04-10 |
| A Phase I/Ⅱ Clinical Trial for Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Ankylosing Spondylitis (NCT07534644) | Shenzhen Huishan Biotechnology Co., Ltd. | 2026-04-10 |
| A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer (NCT07535463) | Memorial Sloan Kettering Cancer Center | 2026-04-10 |
| A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults (NCT07513571) | AstraZeneca | 2026-04-10 |
| Bioequivalence Study of ADC118 Tablets in Healthy Chinese Volunteers Under Fasting Conditions (NCT07753902) | Jiangsu Aidea Pharmaceutical Group Co., Ltd. | 2026-04-10 |
| HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia (NCT07137637) | Hangzhou Polymed Biopharmaceuticals, Inc. | 2026-04-10 |
| A Study of HDM2024 in Participants With Advanced Solid Tumors (NCT07539285) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2026-04-10 |
| Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts (NCT07440004) | University of Wisconsin, Madison | 2026-04-10 |
| ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer (NCT07542717) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-04-10 |
| A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases (NCT07304154) | Kite, A Gilead Company | 2026-04-10 |
| Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health) (NCT07527195) | Novo Nordisk A/S | 2026-04-10 |
| Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes (NCT07535307) | Novo Nordisk A/S | 2026-04-10 |
| A Study of HLD-0117 in Patients With Metastatic Breast Cancer (NCT07524855) | Janssen Research & Development, LLC | 2026-04-09 |
| A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fed Conditions (NCT07421388) | Boryung Pharmaceutical Co., Ltd | 2026-04-09 |
| A Study to Evaluate the Effect of Food on the Bioavailability of AJ201, and Safety, Tolerability, and Pharmacokinetics of AJ201 in Japanese and White Healthy Male Participants (NCT07549919) | AnnJi Pharmaceutical Co., Ltd. | 2026-04-09 |
| Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC (NCT07365592) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-04-09 |
| An Open Label Pharmacokinetic Study of ASP-001 Formulations in Healthy Volunteers (NCT07445464) | Aspartes Pharmaceuticals, Inc. | 2026-04-09 |
| Phase 1 Open Label Trial of MST-0312 Alone and in Combination in Subjects With Solid Malignancies (NCT07610941) | Mestag Therapeutics Limited | 2026-04-09 |
| A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female Participants (NCT07537231) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-04-09 |
| Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity (NCT07523711) | Amgen | 2026-04-09 |
| A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer (NCT07535437) | Memorial Sloan Kettering Cancer Center | 2026-04-09 |
| Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) (NCT07297979) | Amgen | 2026-04-08 |
| GTB-5550 in Advanced Solid Tumors (NCT07541573) | Masonic Cancer Center, University of Minnesota | 2026-04-08 |
| A Study to Learn More About How Safe Nurandociguat is and How it Affects the Way the Body Processes Rosuvastatin and Dabigatran in Healthy Adults (NCT07515339) | Bayer | 2026-04-08 |
| Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas (NCT07455032) | Fox Chase Cancer Center | 2026-04-08 |
| A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer (NCT07407283) | Jiangsu HengRui Medicine Co., Ltd. | 2026-04-08 |
| AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors (NCT07403721) | Amgen | 2026-04-08 |
| MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II) (NCT07479485) | Lepu Biopharma Co., Ltd. | 2026-04-08 |
| A Safety and Pharmacokinetics Study of TL-003 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis (NCT07526519) | TrueLab Biopharmaceutical Co., Ltd | 2026-04-08 |
| A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients (NCT06513546) | PLL TX AUSTRALIA PTY LTD | 2026-04-08 |
| Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin (NCT07502001) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2026-04-08 |
| Bioequivalence Study to Compare Selexipag 400 Microgram Film Coated Tablets Versus Uptravi® (Selexipag) 400 Microgram Film Coated Tablets (NCT07694128) | Humanis Saglık Anonim Sirketi | 2026-04-08 |
| A Study to Evaluate Safety and Dosimetry of [18F]4-FDF, a New PET Imaging Agent for Inflammation (NCT07253753) | Yellowbird Diagnostics Inc | 2026-04-08 |
| Phase 1 Study of PF-08046033 in Advanced Solid Tumors (NCT07519655) | Pfizer | 2026-04-08 |
| BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD) (NCT07544160) | iCell Gene Therapeutics | 2026-04-07 |
| HWS116 Monotherapy in Patients With Advanced Solid Tumors (NCT07413328) | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company | 2026-04-07 |
| A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer (NCT07532902) | Memorial Sloan Kettering Cancer Center | 2026-04-07 |
| Phase 1 Study of C.001 in Retinal Degeneration (NCT07594236) | Cellio Therapeutics Inc | 2026-04-07 |